iPSC for modeling neurodegenerative disorders

Bach, 1968, Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome, Lancet, 2, 1364, 10.1016/S0140-6736(68)92672-X Takahashi, 2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024 Till, 1961, A direct measurement of the radiation sensitivity of normal mouse bone marrow cells, Radiat Res, 14, 213, 10.2307/3570892 Edwards, 1970, Fertilization and cleavage in vitro of preovulator human oocytes, Nature, 227, 1307, 10.1038/2271307a0 Gearhart, 1998, Cell biology: new potential for human embryonic stem cells, Science, 282, 1061, 10.1126/science.282.5391.1061 Thomson, 1998, Embryonic stem cell lines derived from human blastocysts, Science, 282, 1145, 10.1126/science.282.5391.1145 Ittner, 2015, FTD and ALS-translating mouse studies into clinical trials, Nat Rev Neurol, 11, 360, 10.1038/nrneurol.2015.65 Nugraha, 2019, Human cardiac organoids for disease modeling, Clin Pharmacol Therapeut, 105, 79, 10.1002/cpt.1286 Schüssler-Fiorenza Rose, 2019, A longitudinal big data approach for precision health, Nat Med, 25, 792, 10.1038/s41591-019-0414-6 Stoddard-Bennett, 2019, Treatment of Parkinson's disease through personalized medicine and induced pluripotent stem cells, Cells, 8, 26, 10.3390/cells8010026 Shi, 2017, Induced pluripotent stem cell technology: a decade of progress, Nat Rev Drug Discov, 16, 115, 10.1038/nrd.2016.245 Hotta, 2015, From genomics to gene therapy: induced pluripotent stem cells meet genome editing, Annu Rev Genet, 49, 47, 10.1146/annurev-genet-112414-054926 Keller, 2000, Decreased levels of proteasome activity and proteasome expression in aging spinal cord, Neuroscience, 98, 149, 10.1016/S0306-4522(00)00067-1 Mullard, 2015, Stem-cell discovery platforms yield first clinical candidates, Nat Rev Drug Discov, 14, 589, 10.1038/nrd4708 Sugai, 2016, Pathological classification of human iPSC-derived neural stem/progenitor cells towards safety assessment of transplantation therapy for CNS diseases, Mol Brain, 9, 85, 10.1186/s13041-016-0265-8 Suárez-Álvarez, 2010, Epigenetic mechanisms regulate MHC and antigen processing molecules in human embryonic and induced pluripotent stem cells, PloS One, 5, 10.1371/journal.pone.0010192 Hockemeyer, 2016, Induced pluripotent stem cells meet genome editing, Cell Stem Cell, 18, 573, 10.1016/j.stem.2016.04.013 Cosset, 2020, Generation of human induced pluripotent stem cell line UNIGEi003-A from skin fibroblasts of an apparently healthy male donor, Stem Cell Res, 48, 101928, 10.1016/j.scr.2020.101928 Chlebanowska, 2020, Origin of the induced pluripotent stem cells affects their differentiation into dopaminergic neurons, Int J Mol Sci, 21, 5705, 10.3390/ijms21165705 Zhang, 2020, Establishment of two induced pluripotent stem cell line from healthy elderly (IPTi005-A and IPTi007-A), Stem Cell Res, 45, 101808, 10.1016/j.scr.2020.101808 Petrenko, 2020, A comparative analysis of multipotent mesenchymal stromal cells derived from different sources, with a focus on neuroregenerative potential, Sci Rep, 10, 4290, 10.1038/s41598-020-61167-z Holmqvist, 2016, Creation of a library of induced pluripotent stem cells from Parkinsonian patients, NPJ Parkinson’s Dis, 2, 16009, 10.1038/npjparkd.2016.9 Park, 2020, Selective elimination of human pluripotent stem cells by Anti-Dsg2 antibody-doxorubicin conjugates, Biomaterials, 259, 120265, 10.1016/j.biomaterials.2020.120265 Zhou, 2020, Generation and characterization of two iPSC lines from human adipose tissue-derived stem cells of healthy donors, Stem Cell Res, 48, 101973, 10.1016/j.scr.2020.101973 Tang, 2019, Generation of two induced pluripotent stem cell (iPSC) lines from human breast milk using episomal reprogramming system, Stem Cell Res, 39, 101511, 10.1016/j.scr.2019.101511 Xu, 2019, Generation of pig induced pluripotent stem cells using an extended pluripotent stem cell culture system, Stem Cell Res Ther, 10, 193, 10.1186/s13287-019-1303-0 Wu, 2016, Stem cells and interspecies chimaeras, Nature, 540, 51, 10.1038/nature20573 Wu, 2017, Interspecies chimerism with mammalian pluripotent stem cells, Cell, 168, 473, 10.1016/j.cell.2016.12.036 Du, 2015, Barriers for deriving transgene-free pig iPS cells with episomal vectors, Stem cells (Dayton, Ohio), 33, 3228, 10.1002/stem.2089 Raj, 2020, Emergence of neuronal diversity during vertebrate brain development, Neuron, 30747 Rupert, 2020, Metagenomic data of bacterial community from different land uses at the river basin, Kelantan, Data Brief, 33, 106351, 10.1016/j.dib.2020.106351 Magoč, 2011, FLASH: fast length adjustment of short reads to improve genome assemblies, Bioinformatics (Oxford, England), 27, 2957, 10.1093/bioinformatics/btr507 Edgar, 2011, UCHIME improves sensitivity and speed of chimera detection, Bioinformatics (Oxford, England), 27, 2194, 10.1093/bioinformatics/btr381 Zhou, 2020, IDRMutPred: predicting disease-associated germline nonsynonymous single nucleotide variants (nsSNVs) in intrinsically disordered regions, Bioinformatics (Oxford, England), 10.1093/bioinformatics/btaa618 Rabinowitz, 2020, SNP-derived PAM analysis tool for allele-specific targeting of genetic variants using CRISPR-cas systems, Front Genet, 11, 851, 10.3389/fgene.2020.00851 Edsall, 1995, Hsien Wu and the first theory of protein denaturation, Adv Protein Chem, 46, 1 Stefl, 2013, Molecular mechanisms of disease-causing missense mutations, J Mol Biol, 425, 3919, 10.1016/j.jmb.2013.07.014 Rowe, 2019, Induced pluripotent stem cells in disease modelling and drug discovery, Nat Rev Genet, 20, 377, 10.1038/s41576-019-0100-z Onos, 2016, Toward more predictive genetic mouse models of Alzheimer's disease, Brain Res Bull, 122, 1, 10.1016/j.brainresbull.2015.12.003 Studer, 2015, Programming and reprogramming cellular age in the era of induced pluripotency, Cell Stem Cell, 16, 591, 10.1016/j.stem.2015.05.004 Nguyen, 2011, LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress, Cell Stem Cell, 8, 267, 10.1016/j.stem.2011.01.013 Lancaster, 2014, Organogenesis in a dish: modeling development and disease using organoid technologies, Science, 345, 10.1126/science.1247125 Fu, 2018, Selective vulnerability in neurodegenerative diseases, Nat Neurosci, 21, 1350, 10.1038/s41593-018-0221-2 Gan, 2018, Converging pathways in neurodegeneration, from genetics to mechanisms, Nat Neurosci, 21, 1300, 10.1038/s41593-018-0237-7 Pacelli, 2015, Elevated mitochondrial bioenergetics and axonal arborization size are key contributors to the vulnerability of dopamine neurons, Curr Biol, 25, 2349, 10.1016/j.cub.2015.07.050 Alexander, 2004, Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder, Dialogues Clin Neurosci, 6, 259, 10.31887/DCNS.2004.6.3/galexander Masato, 2019, Impaired dopamine metabolism in Parkinson's disease pathogenesis, Mol Neurodegener, 14, 35, 10.1186/s13024-019-0332-6 Hashimoto, 2004, The Role of alpha-synuclein assembly and metabolism in the pathogenesis of Lewy body disease, J Mol Neurosci: MN, 24, 343, 10.1385/JMN:24:3:343 Dettmer, 2015, Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation, Nat Commun, 6, 7314, 10.1038/ncomms8314 Ambasudhan, 2013, Isogenic human iPSC Parkinson’s model shows nitrosative stress-induced dysfunction in MEF2-PGC1α transcription, Cell, 155, 1351, 10.1016/j.cell.2013.11.009 Ludtmann, 2018, α-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson’s disease, Nat Commun, 9, 2293, 10.1038/s41467-018-04422-2 Cooper, 2012, Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson’s disease, Sci Transl Med, 4, 141ra90, 10.1126/scitranslmed.3003985 Shaltouki, 2015, Mitochondrial alterations by PARKIN in dopaminergic neurons using PARK2 patient-specific and PARK2 knockout isogenic iPSC lines, Stem Cell Rep, 4, 847, 10.1016/j.stemcr.2015.02.019 Jiang, 2012, Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells, Nat Commun, 3, 668, 10.1038/ncomms1669 Woodard, 2014, iPSC-derived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson’s disease, Cell Rep, 9, 1173, 10.1016/j.celrep.2014.10.023 Monzel, 2017, Derivation of human midbrain-specific organoids from neuroepithelial stem cells, Stem cell Rep, 8, 1144, 10.1016/j.stemcr.2017.03.010 Wu, 2019, Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease, Open Biol, 9, 180177, 10.1098/rsob.180177 Falkenburger, 2016, Cellular models for Parkinson's disease, J Neurochem, 139, 121, 10.1111/jnc.13618 Jang, 2016, The neuroprotective effect of erythropoietin on rotenone-induced neurotoxicity in SH-SY5Y cells through the induction of autophagy, Mol Neurobiol, 53, 3812, 10.1007/s12035-015-9316-x Lotharius, 2002, Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line, J Biol Chem, 277, 38884, 10.1074/jbc.M205518200 Laperle, 2020, iPSC modeling of young-onset Parkinson’s disease reveals a molecular signature of disease and novel therapeutic candidates, Nat Med, 26, 289, 10.1038/s41591-019-0739-1 Smith, 2020, Astrocyte unfolded protein response induces a specific reactivity state that causes non-cell-autonomous neuronal degeneration, Neuron, 105, 855, 10.1016/j.neuron.2019.12.014 Wray, 2009, Linking amyloid and tau pathology in Alzheimer's disease: the role of membrane cholesterol in Abeta-mediated tau toxicity, J Neurosci : Off J Soc Neurosci, 29, 9665, 10.1523/JNEUROSCI.2234-09.2009 Masters, 2015, Alzheimer's disease, Nat Rev Dis Prim, 1, 15056, 10.1038/nrdp.2015.56 Kondo, 2013, Modeling Alzheimer’s disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness, Cell Stem Cell, 12, 487, 10.1016/j.stem.2013.01.009 De Strooper, 2016, The cellular phase of alzheimer's disease, Cell, 164, 603, 10.1016/j.cell.2015.12.056 Butterfield, 2019, Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease, Nat Rev Neurosci, 20, 148, 10.1038/s41583-019-0132-6 Demetrius, 2013, Alzheimer's as a metabolic disease, Biogerontology, 14, 641-649, 10.1007/s10522-013-9479-7 Cornwell, 1980, Senile amyloidosis: a protean manifestation of the aging process, J Clin Pathol, 33, 1146, 10.1136/jcp.33.12.1146 Demetrius, 2004, Caloric restriction, metabolic rate, and entropy, J Gerontol A Biol Sci Med Sci, 59, B902, 10.1093/gerona/59.9.B902 Zhu, 2007, Alzheimer disease, the two-hit hypothesis: an update, Biochim Biophys Acta, 1772, 494, 10.1016/j.bbadis.2006.10.014 Israel, 2012, Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells, Nature, 482, 216, 10.1038/nature10821 Wang, 2018, Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector, Nat Med, 24, 647, 10.1038/s41591-018-0004-z Lin, 2018, APOE4 causes widespread molecular and cellular alterations associated with Alzheimer’s disease phenotypes in human iPSC-derived brain cell types, Neuron, 98, 1141, 10.1016/j.neuron.2018.05.008 Oksanen, 2017, PSEN1 mutant iPSC-derived model reveals severe astrocyte pathology in alzheimer’s disease, Stem cell Rep, 9, 1885, 10.1016/j.stemcr.2017.10.016 Pearl, 2012, Pluripotent stem cells: immune to the immune system?, Sci Transl Med, 4, 10.1126/scitranslmed.3005090 Doss, 2019, Current challenges of iPSC-based disease modeling and therapeutic implications, Cells, 8, 403, 10.3390/cells8050403 Yin, 2016, Engineering stem cell organoids, Cell Stem Cell, 18, 25, 10.1016/j.stem.2015.12.005 Lund, 2012, Genetic and epigenetic stability of human pluripotent stem cells, Nat Rev Genet, 13, 732, 10.1038/nrg3271